| Particulars |
| Company Name |
Sun Pharmaceutical Industries Ltd |
| Face Value |
1 |
| BSE Code |
524715 |
| Year End |
202403 |
| Full Year |
| Equity (Rs . Cr) |
239.93 |
| B.V. (Rs) |
98.30 |
| Sales (Rs . Cr) |
20,275.17 |
| NP (Rs . Cr) |
3,051.64 |
| NP Var% |
-9.00 |
| Div% |
1,350.00 |
| CPS (Rs) |
19.40 |
| EPS (Rs) |
12.70 |
| Traded Value(Rs . Lakhs) |
629.08 |
| 52 Week High |
1,960.00 |
| 52 Week Low |
1,377.00 |
| Price BSE |
1,842.00 |
| Price NSE |
1,842.00 |
| Market Capital(Rs . Cr) |
441,909.51 |
| P/C Ratio |
95.00 |
| P/E Ratio |
144.80 |
| Price Vs.BV |
18.74 |
| Latest Quarter |
| Year End |
202412 |
| Sales (Rs . Cr) |
5,985.33 |
| NP (Rs . Cr) |
1,181.05 |
| NP Var % |
50.00 |
| Trailing Twelve Months |
| Year End |
202412 |
| Sales |
19,974.06 |
| OPM |
26.45 |
| NP |
2,757.03 |
| NP Var% |
-23.55 |
| EPS |
13.13 |
| PE |
140.27 |
|